Sirolimus-induced intractable chronic diarrhea: A case report

被引:9
作者
Alkhatib, A. A. [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA
关键词
D O I
10.1016/j.transproceed.2006.02.123
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sirolimus is a macrolide that is extensively used in transplant clinics. The most common side effects of sirolimus are hypertriglyceridemia, hypercholesterolemia, hypertension, rash, and well-tolerated diarrhea. Herein I have reported a case of intractable, disabling, chronic diarrhea secondary to sirolimus in a renal transplant recipient. The sirolimus dose had been recently increased from 2 mg to 5 mg 1 month before the patient began to complain of severe diarrhea., In addition to the case presentation, the literature is reviewed as well as possible mechanisms of sirolimus-induced diarrhea are discussed. In conclusion, clinicians should consider sirolimus as a potential etiology for severe chronic diarrhea among patients who are treated with sirolimus.
引用
收藏
页码:1298 / 1300
页数:3
相关论文
共 11 条
[1]  
DEKOCK JC, 1987, LANCET, V2, P564
[2]   Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbits [J].
Dias, VC ;
Madsen, KL ;
Mulder, KE ;
Keelan, M ;
Yatscoff, RW ;
Thomson, ABR .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (10) :2227-2236
[3]   Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus [J].
Fairbanks, KD ;
Eustace, JA ;
Fine, D ;
Thuluvath, PJ .
LIVER TRANSPLANTATION, 2003, 9 (10) :1079-1085
[4]   Diarrhea in liver transplant recipients: Etiology and management [J].
Ginsburg, PM ;
Thuluvath, PJ .
LIVER TRANSPLANTATION, 2005, 11 (08) :881-890
[5]   A retrospective review of sirolimus (rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection [J].
Neff, GW ;
Montalbano, M ;
Slapak-Green, G ;
Berney, T ;
Bejarano, PA ;
Joshi, A ;
Icardi, M ;
Nery, J ;
Seigo, N ;
Levi, D ;
Weppler, D ;
Pappas, P ;
Ruiz, V ;
Schiff, ER ;
Tzakis, AG .
LIVER TRANSPLANTATION, 2003, 9 (05) :477-483
[6]   Gastrointestinal complications in renal transplant recipients [J].
Ponticelli, C ;
Passerini, P .
TRANSPLANT INTERNATIONAL, 2005, 18 (06) :643-650
[7]   The pathophysiology of diarrhea [J].
Sellin, JH .
CLINICAL TRANSPLANTATION, 2001, 15 :2-10
[8]   Sirolimus: A new agent for prevention of renal allograft rejection [J].
Vazquez, EM .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (05) :437-448
[9]   Safety of mycophenolate mofetil versus azathioprine in renal transplantation: A systematic review [J].
Wang, K ;
Zhang, H ;
Li, Y ;
Wei, Q ;
Li, H ;
Yang, Y ;
Lu, Y .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) :2068-2070
[10]   Sirolimus in chronic allograft nephropathy [J].
Wu, MJ ;
Shu, KH ;
Cheng, CH ;
Chen, CH .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) :2053-2055